nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—lung cancer	0.176	0.54	CbGaD
Betamethasone—ABCB1—lung cancer	0.15	0.46	CbGaD
Betamethasone—CYP19A1—Paclitaxel—lung cancer	0.056	0.144	CbGbCtD
Betamethasone—PTGS2—Cisplatin—lung cancer	0.0289	0.074	CbGbCtD
Betamethasone—PTGS2—Etoposide—lung cancer	0.0283	0.0727	CbGbCtD
Betamethasone—ABCB1—Topotecan—lung cancer	0.0239	0.0613	CbGbCtD
Betamethasone—ABCB1—Gefitinib—lung cancer	0.0219	0.0561	CbGbCtD
Betamethasone—ABCB1—Vinorelbine—lung cancer	0.0168	0.0432	CbGbCtD
Betamethasone—CYP3A4—Topotecan—lung cancer	0.0143	0.0367	CbGbCtD
Betamethasone—ABCB1—Crizotinib—lung cancer	0.0134	0.0344	CbGbCtD
Betamethasone—CYP3A4—Gefitinib—lung cancer	0.0131	0.0336	CbGbCtD
Betamethasone—ABCB1—Gemcitabine—lung cancer	0.0131	0.0336	CbGbCtD
Betamethasone—ABCB1—Erlotinib—lung cancer	0.0129	0.0332	CbGbCtD
Betamethasone—CYP3A4—Teniposide—lung cancer	0.0127	0.0326	CbGbCtD
Betamethasone—ABCB1—Paclitaxel—lung cancer	0.0118	0.0304	CbGbCtD
Betamethasone—ABCB1—Irinotecan—lung cancer	0.0117	0.0299	CbGbCtD
Betamethasone—ABCB1—Vinblastine—lung cancer	0.0104	0.0266	CbGbCtD
Betamethasone—CYP3A4—Vinorelbine—lung cancer	0.0101	0.0259	CbGbCtD
Betamethasone—ABCB1—Cisplatin—lung cancer	0.00952	0.0244	CbGbCtD
Betamethasone—ABCB1—Etoposide—lung cancer	0.00935	0.024	CbGbCtD
Betamethasone—ABCB1—Docetaxel—lung cancer	0.00856	0.0219	CbGbCtD
Betamethasone—CYP3A4—Crizotinib—lung cancer	0.00803	0.0206	CbGbCtD
Betamethasone—CYP3A4—Erlotinib—lung cancer	0.00775	0.0199	CbGbCtD
Betamethasone—CYP3A4—Paclitaxel—lung cancer	0.00709	0.0182	CbGbCtD
Betamethasone—CYP3A4—Irinotecan—lung cancer	0.007	0.0179	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—lung cancer	0.00638	0.0164	CbGbCtD
Betamethasone—CYP3A4—Vinblastine—lung cancer	0.00622	0.0159	CbGbCtD
Betamethasone—ABCB1—Methotrexate—lung cancer	0.00618	0.0158	CbGbCtD
Betamethasone—CYP3A4—Etoposide—lung cancer	0.0056	0.0144	CbGbCtD
Betamethasone—CYP3A4—Docetaxel—lung cancer	0.00513	0.0131	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—lung cancer	0.00382	0.0098	CbGbCtD
Betamethasone—PLA2G1B—respiratory system—lung cancer	0.00205	0.109	CbGeAlD
Betamethasone—PLA2G1B—epithelium—lung cancer	0.00171	0.0908	CbGeAlD
Betamethasone—PGR—mammary gland—lung cancer	0.00141	0.0751	CbGeAlD
Betamethasone—PLA2G1B—lung—lung cancer	0.00109	0.0577	CbGeAlD
Betamethasone—Amcinonide—ANXA1—lung cancer	0.00107	0.319	CrCbGaD
Betamethasone—PGR—respiratory system—lung cancer	0.000942	0.05	CbGeAlD
Betamethasone—NR3C2—bronchus—lung cancer	0.000834	0.0443	CbGeAlD
Betamethasone—PGR—epithelium—lung cancer	0.000787	0.0418	CbGeAlD
Betamethasone—NR3C2—trachea—lung cancer	0.000749	0.0398	CbGeAlD
Betamethasone—NR3C2—cardiac atrium—lung cancer	0.000704	0.0374	CbGeAlD
Betamethasone—NR3C1—respiratory system—lung cancer	0.000544	0.0289	CbGeAlD
Betamethasone—NR3C2—lung—lung cancer	0.000538	0.0286	CbGeAlD
Betamethasone—PGR—lung—lung cancer	0.0005	0.0266	CbGeAlD
Betamethasone—PTGS2—respiratory system—lung cancer	0.000471	0.025	CbGeAlD
Betamethasone—NR3C1—epithelium—lung cancer	0.000454	0.0241	CbGeAlD
Betamethasone—Hydrocortisone—ANXA1—lung cancer	0.00045	0.134	CrCbGaD
Betamethasone—NR3C1—bronchus—lung cancer	0.000447	0.0238	CbGeAlD
Betamethasone—NR3C1—trachea—lung cancer	0.000402	0.0213	CbGeAlD
Betamethasone—PTGS2—epithelium—lung cancer	0.000393	0.0209	CbGeAlD
Betamethasone—PTGS2—bronchus—lung cancer	0.000387	0.0206	CbGeAlD
Betamethasone—NR3C1—cardiac atrium—lung cancer	0.000377	0.02	CbGeAlD
Betamethasone—NR3C2—lymph node—lung cancer	0.000368	0.0195	CbGeAlD
Betamethasone—PTGS2—trachea—lung cancer	0.000348	0.0185	CbGeAlD
Betamethasone—PGR—lymph node—lung cancer	0.000342	0.0182	CbGeAlD
Betamethasone—Dexamethasone—ANXA1—lung cancer	0.000335	0.1	CrCbGaD
Betamethasone—NR3C1—bone marrow—lung cancer	0.000319	0.0169	CbGeAlD
Betamethasone—CYP19A1—lymph node—lung cancer	0.000308	0.0164	CbGeAlD
Betamethasone—ABCB1—respiratory system—lung cancer	0.000291	0.0155	CbGeAlD
Betamethasone—NR3C1—lung—lung cancer	0.000289	0.0153	CbGeAlD
Betamethasone—PTGS2—bone marrow—lung cancer	0.000276	0.0146	CbGeAlD
Betamethasone—PTGS2—lung—lung cancer	0.00025	0.0133	CbGeAlD
Betamethasone—ABCB1—epithelium—lung cancer	0.000243	0.0129	CbGeAlD
Betamethasone—ABCB1—trachea—lung cancer	0.000215	0.0114	CbGeAlD
Betamethasone—NR3C1—lymph node—lung cancer	0.000197	0.0105	CbGeAlD
Betamethasone—Clobetasol propionate—CYP1A1—lung cancer	0.000192	0.0575	CrCbGaD
Betamethasone—Prednisolone—CYP2A6—lung cancer	0.00018	0.0539	CrCbGaD
Betamethasone—PTGS2—lymph node—lung cancer	0.000171	0.00907	CbGeAlD
Betamethasone—ABCB1—bone marrow—lung cancer	0.000171	0.00906	CbGeAlD
Betamethasone—ABCB1—lung—lung cancer	0.000155	0.00821	CbGeAlD
Betamethasone—Hydrocortisone—ABCG2—lung cancer	0.000123	0.0369	CrCbGaD
Betamethasone—Fluticasone furoate—ABCB1—lung cancer	0.00012	0.0357	CrCbGaD
Betamethasone—ABCB1—lymph node—lung cancer	0.000106	0.00561	CbGeAlD
Betamethasone—Dexamethasone—CYP2A6—lung cancer	0.000103	0.0307	CrCbGaD
Betamethasone—Methylprednisolone—ABCB1—lung cancer	9.53e-05	0.0285	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—lung cancer	9.45e-05	0.0282	CrCbGaD
Betamethasone—Dexamethasone—ABCG2—lung cancer	9.2e-05	0.0275	CrCbGaD
Betamethasone—Myalgia—Paclitaxel—lung cancer	8.23e-05	0.000485	CcSEcCtD
Betamethasone—Hypotension—Cisplatin—lung cancer	8.21e-05	0.000484	CcSEcCtD
Betamethasone—Anxiety—Paclitaxel—lung cancer	8.21e-05	0.000483	CcSEcCtD
Betamethasone—Erythema—Docetaxel—lung cancer	8.2e-05	0.000483	CcSEcCtD
Betamethasone—Decreased appetite—Gemcitabine—lung cancer	8.2e-05	0.000483	CcSEcCtD
Betamethasone—Nausea—Topotecan—lung cancer	8.15e-05	0.00048	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Gemcitabine—lung cancer	8.14e-05	0.000479	CcSEcCtD
Betamethasone—Discomfort—Paclitaxel—lung cancer	8.14e-05	0.000479	CcSEcCtD
Betamethasone—Fatigue—Gemcitabine—lung cancer	8.13e-05	0.000479	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—lung cancer	8.08e-05	0.000476	CcSEcCtD
Betamethasone—Pain—Gemcitabine—lung cancer	8.06e-05	0.000475	CcSEcCtD
Betamethasone—Nausea—Erlotinib—lung cancer	8.06e-05	0.000475	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—lung cancer	8.05e-05	0.000474	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—lung cancer	8.05e-05	0.000474	CcSEcCtD
Betamethasone—Diarrhoea—Vinorelbine—lung cancer	8.03e-05	0.000473	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Cisplatin—lung cancer	8.01e-05	0.000472	CcSEcCtD
Betamethasone—Infection—Etoposide—lung cancer	8e-05	0.000471	CcSEcCtD
Betamethasone—Feeling abnormal—Irinotecan—lung cancer	7.98e-05	0.00047	CcSEcCtD
Betamethasone—Gastrointestinal pain—Irinotecan—lung cancer	7.91e-05	0.000466	CcSEcCtD
Betamethasone—Anaphylactic shock—Paclitaxel—lung cancer	7.89e-05	0.000465	CcSEcCtD
Betamethasone—Oedema—Paclitaxel—lung cancer	7.89e-05	0.000465	CcSEcCtD
Betamethasone—Paraesthesia—Cisplatin—lung cancer	7.89e-05	0.000465	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—lung cancer	7.88e-05	0.000464	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—lung cancer	7.86e-05	0.000463	CcSEcCtD
Betamethasone—Infection—Paclitaxel—lung cancer	7.84e-05	0.000462	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—lung cancer	7.79e-05	0.000459	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—lung cancer	7.78e-05	0.000458	CcSEcCtD
Betamethasone—Feeling abnormal—Gemcitabine—lung cancer	7.77e-05	0.000458	CcSEcCtD
Betamethasone—Shock—Paclitaxel—lung cancer	7.77e-05	0.000457	CcSEcCtD
Betamethasone—Dizziness—Vinorelbine—lung cancer	7.76e-05	0.000457	CcSEcCtD
Betamethasone—Nervous system disorder—Paclitaxel—lung cancer	7.74e-05	0.000456	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—lung cancer	7.73e-05	0.000455	CcSEcCtD
Betamethasone—Thrombocytopenia—Paclitaxel—lung cancer	7.73e-05	0.000455	CcSEcCtD
Betamethasone—Tachycardia—Paclitaxel—lung cancer	7.7e-05	0.000454	CcSEcCtD
Betamethasone—Anorexia—Etoposide—lung cancer	7.67e-05	0.000452	CcSEcCtD
Betamethasone—Abdominal pain—Irinotecan—lung cancer	7.65e-05	0.000451	CcSEcCtD
Betamethasone—Body temperature increased—Irinotecan—lung cancer	7.65e-05	0.000451	CcSEcCtD
Betamethasone—Decreased appetite—Cisplatin—lung cancer	7.64e-05	0.00045	CcSEcCtD
Betamethasone—Prednisone—ALB—lung cancer	7.64e-05	0.0228	CrCbGaD
Betamethasone—Hyperhidrosis—Paclitaxel—lung cancer	7.63e-05	0.000449	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Cisplatin—lung cancer	7.59e-05	0.000447	CcSEcCtD
Betamethasone—Anorexia—Paclitaxel—lung cancer	7.52e-05	0.000443	CcSEcCtD
Betamethasone—Hypotension—Etoposide—lung cancer	7.52e-05	0.000443	CcSEcCtD
Betamethasone—Pain—Cisplatin—lung cancer	7.51e-05	0.000443	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—lung cancer	7.49e-05	0.000441	CcSEcCtD
Betamethasone—Vomiting—Vinorelbine—lung cancer	7.46e-05	0.000439	CcSEcCtD
Betamethasone—Body temperature increased—Gemcitabine—lung cancer	7.45e-05	0.000439	CcSEcCtD
Betamethasone—Rash—Vinorelbine—lung cancer	7.4e-05	0.000436	CcSEcCtD
Betamethasone—Dermatitis—Vinorelbine—lung cancer	7.39e-05	0.000435	CcSEcCtD
Betamethasone—Hypotension—Paclitaxel—lung cancer	7.38e-05	0.000434	CcSEcCtD
Betamethasone—Headache—Vinorelbine—lung cancer	7.35e-05	0.000433	CcSEcCtD
Betamethasone—Syncope—Docetaxel—lung cancer	7.35e-05	0.000433	CcSEcCtD
Betamethasone—Conjunctivitis—Methotrexate—lung cancer	7.35e-05	0.000433	CcSEcCtD
Betamethasone—Dexamethasone—CYP2E1—lung cancer	7.3e-05	0.0218	CrCbGaD
Betamethasone—Prednisone—ABCB1—lung cancer	7.29e-05	0.0218	CrCbGaD
Betamethasone—Feeling abnormal—Cisplatin—lung cancer	7.24e-05	0.000427	CcSEcCtD
Betamethasone—Paraesthesia—Etoposide—lung cancer	7.23e-05	0.000426	CcSEcCtD
Betamethasone—Loss of consciousness—Docetaxel—lung cancer	7.21e-05	0.000424	CcSEcCtD
Betamethasone—Dexamethasone—CYP1A1—lung cancer	7.2e-05	0.0215	CrCbGaD
Betamethasone—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.19e-05	0.000424	CcSEcCtD
Betamethasone—Insomnia—Paclitaxel—lung cancer	7.14e-05	0.00042	CcSEcCtD
Betamethasone—Convulsion—Docetaxel—lung cancer	7.1e-05	0.000418	CcSEcCtD
Betamethasone—Paraesthesia—Paclitaxel—lung cancer	7.09e-05	0.000417	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—lung cancer	7.08e-05	0.000417	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—lung cancer	7e-05	0.000412	CcSEcCtD
Betamethasone—Myalgia—Docetaxel—lung cancer	6.98e-05	0.000411	CcSEcCtD
Betamethasone—Nausea—Vinorelbine—lung cancer	6.97e-05	0.000411	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—lung cancer	6.95e-05	0.000409	CcSEcCtD
Betamethasone—Dyspepsia—Paclitaxel—lung cancer	6.95e-05	0.000409	CcSEcCtD
Betamethasone—Body temperature increased—Cisplatin—lung cancer	6.95e-05	0.000409	CcSEcCtD
Betamethasone—Asthenia—Irinotecan—lung cancer	6.94e-05	0.000409	CcSEcCtD
Betamethasone—Fatigue—Etoposide—lung cancer	6.94e-05	0.000409	CcSEcCtD
Betamethasone—Pain—Etoposide—lung cancer	6.88e-05	0.000405	CcSEcCtD
Betamethasone—Decreased appetite—Paclitaxel—lung cancer	6.86e-05	0.000404	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—lung cancer	6.82e-05	0.000402	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Paclitaxel—lung cancer	6.81e-05	0.000401	CcSEcCtD
Betamethasone—Fatigue—Paclitaxel—lung cancer	6.81e-05	0.000401	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—lung cancer	6.79e-05	0.0004	CcSEcCtD
Betamethasone—Asthenia—Gemcitabine—lung cancer	6.76e-05	0.000398	CcSEcCtD
Betamethasone—Pain—Paclitaxel—lung cancer	6.75e-05	0.000398	CcSEcCtD
Betamethasone—Prednisolone—ABCB1—lung cancer	6.72e-05	0.0201	CrCbGaD
Betamethasone—Anaphylactic shock—Docetaxel—lung cancer	6.69e-05	0.000394	CcSEcCtD
Betamethasone—Oedema—Docetaxel—lung cancer	6.69e-05	0.000394	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—lung cancer	6.68e-05	0.000394	CcSEcCtD
Betamethasone—Pruritus—Gemcitabine—lung cancer	6.67e-05	0.000393	CcSEcCtD
Betamethasone—Infection—Docetaxel—lung cancer	6.65e-05	0.000391	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—lung cancer	6.64e-05	0.000391	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—lung cancer	6.63e-05	0.000391	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—lung cancer	6.62e-05	0.00039	CcSEcCtD
Betamethasone—Diarrhoea—Irinotecan—lung cancer	6.62e-05	0.00039	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—lung cancer	6.58e-05	0.000388	CcSEcCtD
Betamethasone—Shock—Docetaxel—lung cancer	6.58e-05	0.000388	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—lung cancer	6.56e-05	0.000386	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—lung cancer	6.55e-05	0.000386	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—lung cancer	6.54e-05	0.000385	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—lung cancer	6.53e-05	0.000385	CcSEcCtD
Betamethasone—Feeling abnormal—Paclitaxel—lung cancer	6.5e-05	0.000383	CcSEcCtD
Betamethasone—Gastrointestinal pain—Paclitaxel—lung cancer	6.45e-05	0.00038	CcSEcCtD
Betamethasone—Diarrhoea—Gemcitabine—lung cancer	6.45e-05	0.00038	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—lung cancer	6.42e-05	0.000378	CcSEcCtD
Betamethasone—Dizziness—Irinotecan—lung cancer	6.4e-05	0.000377	CcSEcCtD
Betamethasone—Urticaria—Etoposide—lung cancer	6.4e-05	0.000377	CcSEcCtD
Betamethasone—Anorexia—Docetaxel—lung cancer	6.38e-05	0.000376	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—lung cancer	6.36e-05	0.000375	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—lung cancer	6.36e-05	0.000375	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—lung cancer	6.36e-05	0.000375	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—lung cancer	6.34e-05	0.000374	CcSEcCtD
Betamethasone—Asthenia—Cisplatin—lung cancer	6.3e-05	0.000371	CcSEcCtD
Betamethasone—Urticaria—Paclitaxel—lung cancer	6.27e-05	0.000369	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—lung cancer	6.25e-05	0.000368	CcSEcCtD
Betamethasone—Abdominal pain—Paclitaxel—lung cancer	6.24e-05	0.000368	CcSEcCtD
Betamethasone—Body temperature increased—Paclitaxel—lung cancer	6.24e-05	0.000368	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—lung cancer	6.16e-05	0.000363	CcSEcCtD
Betamethasone—Vomiting—Irinotecan—lung cancer	6.15e-05	0.000362	CcSEcCtD
Betamethasone—Rash—Irinotecan—lung cancer	6.1e-05	0.000359	CcSEcCtD
Betamethasone—Dermatitis—Irinotecan—lung cancer	6.1e-05	0.000359	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Docetaxel—lung cancer	6.1e-05	0.000359	CcSEcCtD
Betamethasone—Headache—Irinotecan—lung cancer	6.06e-05	0.000357	CcSEcCtD
Betamethasone—Insomnia—Docetaxel—lung cancer	6.05e-05	0.000356	CcSEcCtD
Betamethasone—Diarrhoea—Cisplatin—lung cancer	6.01e-05	0.000354	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—lung cancer	6.01e-05	0.000354	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—lung cancer	6e-05	0.000353	CcSEcCtD
Betamethasone—Vomiting—Gemcitabine—lung cancer	5.99e-05	0.000353	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—lung cancer	5.98e-05	0.000352	CcSEcCtD
Betamethasone—Rash—Gemcitabine—lung cancer	5.94e-05	0.00035	CcSEcCtD
Betamethasone—Dermatitis—Gemcitabine—lung cancer	5.94e-05	0.00035	CcSEcCtD
Betamethasone—Erythema—Methotrexate—lung cancer	5.91e-05	0.000348	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—lung cancer	5.91e-05	0.000348	CcSEcCtD
Betamethasone—Headache—Gemcitabine—lung cancer	5.91e-05	0.000348	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—lung cancer	5.89e-05	0.000347	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—lung cancer	5.88e-05	0.000346	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—lung cancer	5.82e-05	0.000343	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—lung cancer	5.78e-05	0.00034	CcSEcCtD
Betamethasone—Asthenia—Etoposide—lung cancer	5.78e-05	0.00034	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—lung cancer	5.77e-05	0.00034	CcSEcCtD
Betamethasone—Nausea—Irinotecan—lung cancer	5.75e-05	0.000339	CcSEcCtD
Betamethasone—Pain—Docetaxel—lung cancer	5.72e-05	0.000337	CcSEcCtD
Betamethasone—Pruritus—Etoposide—lung cancer	5.7e-05	0.000335	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—lung cancer	5.66e-05	0.000334	CcSEcCtD
Betamethasone—Asthenia—Paclitaxel—lung cancer	5.66e-05	0.000334	CcSEcCtD
Betamethasone—Nausea—Gemcitabine—lung cancer	5.6e-05	0.00033	CcSEcCtD
Betamethasone—Vomiting—Cisplatin—lung cancer	5.59e-05	0.000329	CcSEcCtD
Betamethasone—Pruritus—Paclitaxel—lung cancer	5.58e-05	0.000329	CcSEcCtD
Betamethasone—Rash—Cisplatin—lung cancer	5.54e-05	0.000326	CcSEcCtD
Betamethasone—Dermatitis—Cisplatin—lung cancer	5.54e-05	0.000326	CcSEcCtD
Betamethasone—Feeling abnormal—Docetaxel—lung cancer	5.51e-05	0.000325	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—lung cancer	5.51e-05	0.000324	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—lung cancer	5.49e-05	0.000323	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—lung cancer	5.48e-05	0.000323	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—lung cancer	5.47e-05	0.000322	CcSEcCtD
Betamethasone—Diarrhoea—Paclitaxel—lung cancer	5.4e-05	0.000318	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—lung cancer	5.33e-05	0.000314	CcSEcCtD
Betamethasone—Malaise—Methotrexate—lung cancer	5.33e-05	0.000314	CcSEcCtD
Betamethasone—Dizziness—Etoposide—lung cancer	5.32e-05	0.000314	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—lung cancer	5.31e-05	0.000313	CcSEcCtD
Betamethasone—Body temperature increased—Docetaxel—lung cancer	5.29e-05	0.000312	CcSEcCtD
Betamethasone—Abdominal pain—Docetaxel—lung cancer	5.29e-05	0.000312	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—lung cancer	5.25e-05	0.000309	CcSEcCtD
Betamethasone—Dizziness—Paclitaxel—lung cancer	5.22e-05	0.000307	CcSEcCtD
Betamethasone—Nausea—Cisplatin—lung cancer	5.22e-05	0.000307	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—lung cancer	5.19e-05	0.000306	CcSEcCtD
Betamethasone—Hydrocortisone—ABCB1—lung cancer	5.14e-05	0.0153	CrCbGaD
Betamethasone—Convulsion—Methotrexate—lung cancer	5.12e-05	0.000302	CcSEcCtD
Betamethasone—Vomiting—Etoposide—lung cancer	5.12e-05	0.000301	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—lung cancer	5.12e-05	0.000301	CcSEcCtD
Betamethasone—Rash—Etoposide—lung cancer	5.08e-05	0.000299	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—lung cancer	5.07e-05	0.000299	CcSEcCtD
Betamethasone—Headache—Etoposide—lung cancer	5.04e-05	0.000297	CcSEcCtD
Betamethasone—Myalgia—Methotrexate—lung cancer	5.03e-05	0.000296	CcSEcCtD
Betamethasone—Vomiting—Paclitaxel—lung cancer	5.02e-05	0.000296	CcSEcCtD
Betamethasone—Rash—Paclitaxel—lung cancer	4.98e-05	0.000293	CcSEcCtD
Betamethasone—Dermatitis—Paclitaxel—lung cancer	4.97e-05	0.000293	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—lung cancer	4.97e-05	0.000293	CcSEcCtD
Betamethasone—Headache—Paclitaxel—lung cancer	4.94e-05	0.000291	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—lung cancer	4.82e-05	0.000284	CcSEcCtD
Betamethasone—Asthenia—Docetaxel—lung cancer	4.8e-05	0.000283	CcSEcCtD
Betamethasone—Infection—Methotrexate—lung cancer	4.79e-05	0.000282	CcSEcCtD
Betamethasone—Nausea—Etoposide—lung cancer	4.78e-05	0.000282	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—lung cancer	4.75e-05	0.00028	CcSEcCtD
Betamethasone—Pruritus—Docetaxel—lung cancer	4.73e-05	0.000279	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—lung cancer	4.73e-05	0.000279	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—lung cancer	4.72e-05	0.000278	CcSEcCtD
Betamethasone—Nausea—Paclitaxel—lung cancer	4.69e-05	0.000276	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—lung cancer	4.66e-05	0.000275	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—lung cancer	4.61e-05	0.000272	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—lung cancer	4.6e-05	0.000271	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—lung cancer	4.6e-05	0.000271	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—lung cancer	4.59e-05	0.00027	CcSEcCtD
Betamethasone—Diarrhoea—Docetaxel—lung cancer	4.58e-05	0.00027	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—lung cancer	4.51e-05	0.000265	CcSEcCtD
Betamethasone—Dexamethasone—PTGS2—lung cancer	4.5e-05	0.0134	CrCbGaD
Betamethasone—Loss of consciousness—Doxorubicin—lung cancer	4.5e-05	0.000265	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—lung cancer	4.43e-05	0.000261	CcSEcCtD
Betamethasone—Dizziness—Docetaxel—lung cancer	4.42e-05	0.000261	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—lung cancer	4.42e-05	0.00026	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—lung cancer	4.39e-05	0.000259	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—lung cancer	4.36e-05	0.000257	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—lung cancer	4.36e-05	0.000257	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—lung cancer	4.34e-05	0.000256	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—lung cancer	4.33e-05	0.000255	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—lung cancer	4.3e-05	0.000253	CcSEcCtD
Betamethasone—Vomiting—Docetaxel—lung cancer	4.25e-05	0.000251	CcSEcCtD
Betamethasone—Dyspepsia—Methotrexate—lung cancer	4.24e-05	0.00025	CcSEcCtD
Betamethasone—Rash—Docetaxel—lung cancer	4.22e-05	0.000248	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—lung cancer	4.21e-05	0.000248	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—lung cancer	4.19e-05	0.000247	CcSEcCtD
Betamethasone—Headache—Docetaxel—lung cancer	4.19e-05	0.000247	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—lung cancer	4.18e-05	0.000246	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—lung cancer	4.18e-05	0.000246	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—lung cancer	4.16e-05	0.000245	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—lung cancer	4.16e-05	0.000245	CcSEcCtD
Betamethasone—Infection—Doxorubicin—lung cancer	4.15e-05	0.000244	CcSEcCtD
Betamethasone—Pain—Methotrexate—lung cancer	4.12e-05	0.000243	CcSEcCtD
Betamethasone—Shock—Doxorubicin—lung cancer	4.11e-05	0.000242	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—lung cancer	4.09e-05	0.000241	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—lung cancer	4.09e-05	0.000241	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—lung cancer	4.08e-05	0.00024	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—lung cancer	4.04e-05	0.000238	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—lung cancer	3.98e-05	0.000234	CcSEcCtD
Betamethasone—Nausea—Docetaxel—lung cancer	3.97e-05	0.000234	CcSEcCtD
Betamethasone—Feeling abnormal—Methotrexate—lung cancer	3.97e-05	0.000234	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—lung cancer	3.94e-05	0.000232	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—lung cancer	3.9e-05	0.00023	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—lung cancer	3.83e-05	0.000226	CcSEcCtD
Betamethasone—Dexamethasone—ABCB1—lung cancer	3.83e-05	0.0114	CrCbGaD
Betamethasone—Body temperature increased—Methotrexate—lung cancer	3.81e-05	0.000225	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—lung cancer	3.81e-05	0.000225	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.8e-05	0.000224	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—lung cancer	3.78e-05	0.000222	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—lung cancer	3.75e-05	0.000221	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—lung cancer	3.68e-05	0.000216	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—lung cancer	3.63e-05	0.000214	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—lung cancer	3.6e-05	0.000212	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—lung cancer	3.6e-05	0.000212	CcSEcCtD
Betamethasone—Pain—Doxorubicin—lung cancer	3.57e-05	0.00021	CcSEcCtD
Betamethasone—Asthenia—Methotrexate—lung cancer	3.46e-05	0.000204	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—lung cancer	3.44e-05	0.000203	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—lung cancer	3.41e-05	0.000201	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—lung cancer	3.41e-05	0.000201	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—lung cancer	3.32e-05	0.000195	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—lung cancer	3.3e-05	0.000194	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—lung cancer	3.3e-05	0.000194	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—lung cancer	3.3e-05	0.000194	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—lung cancer	3.19e-05	0.000188	CcSEcCtD
Betamethasone—Vomiting—Methotrexate—lung cancer	3.07e-05	0.000181	CcSEcCtD
Betamethasone—Rash—Methotrexate—lung cancer	3.04e-05	0.000179	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—lung cancer	3.04e-05	0.000179	CcSEcCtD
Betamethasone—Headache—Methotrexate—lung cancer	3.02e-05	0.000178	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—lung cancer	3e-05	0.000176	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—lung cancer	2.95e-05	0.000174	CcSEcCtD
Betamethasone—Nausea—Methotrexate—lung cancer	2.86e-05	0.000169	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—lung cancer	2.86e-05	0.000168	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—lung cancer	2.76e-05	0.000163	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—lung cancer	2.65e-05	0.000156	CcSEcCtD
Betamethasone—Rash—Doxorubicin—lung cancer	2.63e-05	0.000155	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—lung cancer	2.63e-05	0.000155	CcSEcCtD
Betamethasone—Headache—Doxorubicin—lung cancer	2.62e-05	0.000154	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—lung cancer	2.48e-05	0.000146	CcSEcCtD
Betamethasone—PTGS2—Metabolism—HPGDS—lung cancer	1.22e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO2—lung cancer	1.22e-05	0.000133	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLBD1—lung cancer	1.22e-05	0.000133	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.21e-05	0.000132	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—lung cancer	1.21e-05	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.000132	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.21e-05	0.000132	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ERCC2—lung cancer	1.2e-05	0.000131	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.2e-05	0.00013	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—B4GALT5—lung cancer	1.2e-05	0.00013	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAT—lung cancer	1.2e-05	0.00013	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.19e-05	0.00013	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTT1—lung cancer	1.18e-05	0.000129	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.17e-05	0.000128	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOA1—lung cancer	1.17e-05	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2A6—lung cancer	1.17e-05	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCLC—lung cancer	1.17e-05	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JUNB—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTA4—lung cancer	1.16e-05	0.000127	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—lung cancer	1.16e-05	0.000127	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—lung cancer	1.16e-05	0.000126	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.15e-05	0.000125	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.15e-05	0.000125	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMS—lung cancer	1.14e-05	0.000124	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTA2—lung cancer	1.14e-05	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—lung cancer	1.13e-05	0.000123	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD17B10—lung cancer	1.11e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO1—lung cancer	1.11e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.11e-05	0.00012	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTA1—lung cancer	1.1e-05	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.09e-05	0.000119	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.09e-05	0.000118	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.09e-05	0.000118	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCC3—lung cancer	1.08e-05	0.000118	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—lung cancer	1.07e-05	0.000117	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A1—lung cancer	1.07e-05	0.000117	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—lung cancer	1.07e-05	0.000117	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KIT—lung cancer	1.07e-05	0.000117	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—lung cancer	1.07e-05	0.000117	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ERCC2—lung cancer	1.06e-05	0.000116	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGF—lung cancer	1.06e-05	0.000115	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C1—lung cancer	1.05e-05	0.000114	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CKB—lung cancer	1.04e-05	0.000113	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—lung cancer	1.03e-05	0.000112	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FOXO3—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—UGT1A1—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—lung cancer	1.02e-05	0.000111	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—lung cancer	1.01e-05	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.97e-06	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2E1—lung cancer	9.95e-06	0.000108	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6R—lung cancer	9.93e-06	0.000108	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CREBBP—lung cancer	9.91e-06	0.000108	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NQO1—lung cancer	9.84e-06	0.000107	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNG11—lung cancer	9.82e-06	0.000107	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM2—lung cancer	9.73e-06	0.000106	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CNDP2—lung cancer	9.73e-06	0.000106	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.65e-06	0.000105	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.64e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTMR3—lung cancer	9.47e-06	0.000103	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K1—lung cancer	9.46e-06	0.000103	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—lung cancer	9.4e-06	0.000102	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALDOA—lung cancer	9.35e-06	0.000102	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—lung cancer	9.3e-06	0.000101	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.29e-06	0.000101	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PGAM1—lung cancer	9.23e-06	0.000101	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOA1—lung cancer	9.18e-06	0.0001	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOA3—lung cancer	9.07e-06	9.89e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES1—lung cancer	9.06e-06	9.87e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—lung cancer	9.05e-06	9.86e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STK11—lung cancer	8.87e-06	9.67e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ADCY1—lung cancer	8.83e-06	9.62e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCG2—lung cancer	8.83e-06	9.62e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CREBBP—lung cancer	8.81e-06	9.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2A7—lung cancer	8.8e-06	9.59e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.79e-06	9.58e-05	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—lung cancer	8.76e-06	9.55e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPGDS—lung cancer	8.66e-06	9.43e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO2—lung cancer	8.66e-06	9.43e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SDC4—lung cancer	8.61e-06	9.39e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPP2R1B—lung cancer	8.6e-06	9.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERCC2—lung cancer	8.47e-06	9.23e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—lung cancer	8.42e-06	9.18e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—lung cancer	8.4e-06	9.15e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAF1—lung cancer	8.39e-06	9.15e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—lung cancer	8.38e-06	9.14e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.33e-06	9.08e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—lung cancer	8.3e-06	9.05e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCLC—lung cancer	8.3e-06	9.04e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2A6—lung cancer	8.3e-06	9.04e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB3—lung cancer	8.28e-06	9.03e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—lung cancer	8.21e-06	8.95e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTOR—lung cancer	8.19e-06	8.93e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—lung cancer	8.19e-06	8.93e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.15e-06	8.88e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAT—lung cancer	7.99e-06	8.71e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—lung cancer	7.98e-06	8.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.94e-06	8.66e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—lung cancer	7.94e-06	8.65e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—lung cancer	7.87e-06	8.58e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO1—lung cancer	7.87e-06	8.57e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.86e-06	8.57e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RRM1—lung cancer	7.85e-06	8.55e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA3—lung cancer	7.85e-06	8.55e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CREBBP—lung cancer	7.77e-06	8.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—lung cancer	7.77e-06	8.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR1—lung cancer	7.71e-06	8.4e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—lung cancer	7.63e-06	8.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—lung cancer	7.59e-06	8.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—lung cancer	7.54e-06	8.22e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—lung cancer	7.54e-06	8.21e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—lung cancer	7.52e-06	8.2e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—B4GALT5—lung cancer	7.38e-06	8.04e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—lung cancer	7.37e-06	8.03e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.36e-06	8.02e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—lung cancer	7.34e-06	7.99e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOA1—lung cancer	7.33e-06	7.98e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JUN—lung cancer	7.32e-06	7.98e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—lung cancer	7.28e-06	7.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA4—lung cancer	7.18e-06	7.82e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—lung cancer	7.15e-06	7.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—lung cancer	7.12e-06	7.76e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—lung cancer	7.1e-06	7.73e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ERCC2—lung cancer	7.09e-06	7.73e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—lung cancer	7.08e-06	7.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2E1—lung cancer	7.06e-06	7.69e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA2—lung cancer	6.99e-06	7.62e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NQO1—lung cancer	6.98e-06	7.6e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—lung cancer	6.75e-06	7.36e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA1—lung cancer	6.75e-06	7.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KIT—lung cancer	6.69e-06	7.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—lung cancer	6.69e-06	7.29e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCC3—lung cancer	6.67e-06	7.27e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.65e-06	7.25e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGF—lung cancer	6.61e-06	7.21e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—lung cancer	6.57e-06	7.15e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C1—lung cancer	6.46e-06	7.04e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—lung cancer	6.42e-06	7e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—lung cancer	6.39e-06	6.97e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—lung cancer	6.36e-06	6.94e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—lung cancer	6.33e-06	6.9e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—lung cancer	6.32e-06	6.88e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STK11—lung cancer	6.29e-06	6.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—lung cancer	6.29e-06	6.85e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—lung cancer	6.28e-06	6.84e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UGT1A1—lung cancer	6.27e-06	6.83e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6R—lung cancer	6.21e-06	6.77e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREBBP—lung cancer	6.2e-06	6.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOA1—lung cancer	6.14e-06	6.69e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—lung cancer	6.05e-06	6.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNG11—lung cancer	6.05e-06	6.59e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K1—lung cancer	5.92e-06	6.45e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—lung cancer	5.88e-06	6.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—lung cancer	5.88e-06	6.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.88e-06	6.4e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—lung cancer	5.82e-06	6.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALDOA—lung cancer	5.76e-06	6.28e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—lung cancer	5.75e-06	6.27e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAT—lung cancer	5.66e-06	6.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—lung cancer	5.6e-06	6.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA3—lung cancer	5.59e-06	6.09e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—lung cancer	5.55e-06	6.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG2—lung cancer	5.44e-06	5.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ADCY1—lung cancer	5.44e-06	5.93e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—lung cancer	5.44e-06	5.92e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—lung cancer	5.41e-06	5.9e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—lung cancer	5.38e-06	5.86e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—lung cancer	5.35e-06	5.83e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPGDS—lung cancer	5.33e-06	5.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO2—lung cancer	5.33e-06	5.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—lung cancer	5.33e-06	5.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.3e-06	5.78e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—lung cancer	5.29e-06	5.77e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—lung cancer	5.27e-06	5.74e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAF1—lung cancer	5.25e-06	5.72e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—lung cancer	5.23e-06	5.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CREBBP—lung cancer	5.19e-06	5.66e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—lung cancer	5.19e-06	5.66e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—lung cancer	5.17e-06	5.64e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—lung cancer	5.13e-06	5.59e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTOR—lung cancer	5.13e-06	5.59e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—lung cancer	5.12e-06	5.57e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2A6—lung cancer	5.11e-06	5.57e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCLC—lung cancer	5.11e-06	5.57e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—lung cancer	5.07e-06	5.52e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ERCC2—lung cancer	5.03e-06	5.48e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—lung cancer	4.99e-06	5.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—lung cancer	4.92e-06	5.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—lung cancer	4.86e-06	5.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO1—lung cancer	4.85e-06	5.28e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—lung cancer	4.83e-06	5.27e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—lung cancer	4.62e-06	5.04e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—lung cancer	4.44e-06	4.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—lung cancer	4.43e-06	4.83e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—lung cancer	4.42e-06	4.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA1—lung cancer	4.35e-06	4.74e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.35e-06	4.74e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NQO1—lung cancer	4.3e-06	4.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—lung cancer	4.29e-06	4.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—lung cancer	4.22e-06	4.6e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—lung cancer	4.11e-06	4.48e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—lung cancer	4.08e-06	4.45e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—lung cancer	3.97e-06	4.33e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—lung cancer	3.96e-06	4.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—lung cancer	3.95e-06	4.31e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—lung cancer	3.92e-06	4.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STK11—lung cancer	3.87e-06	4.22e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—lung cancer	3.78e-06	4.12e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—lung cancer	3.78e-06	4.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—lung cancer	3.71e-06	4.04e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CREBBP—lung cancer	3.68e-06	4.01e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—lung cancer	3.68e-06	4.01e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—lung cancer	3.63e-06	3.95e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—lung cancer	3.6e-06	3.92e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—lung cancer	3.59e-06	3.91e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—lung cancer	3.54e-06	3.85e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—lung cancer	3.49e-06	3.8e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAT—lung cancer	3.49e-06	3.8e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—lung cancer	3.45e-06	3.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—lung cancer	3.4e-06	3.71e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—lung cancer	3.39e-06	3.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—lung cancer	3.33e-06	3.63e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—lung cancer	3.29e-06	3.59e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—lung cancer	3.2e-06	3.49e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—lung cancer	3.12e-06	3.4e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.12e-06	3.4e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ERCC2—lung cancer	3.1e-06	3.38e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—lung cancer	3.04e-06	3.32e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—lung cancer	3.01e-06	3.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—lung cancer	2.89e-06	3.15e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—lung cancer	2.77e-06	3.01e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA1—lung cancer	2.68e-06	2.92e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—lung cancer	2.63e-06	2.87e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—lung cancer	2.62e-06	2.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—lung cancer	2.55e-06	2.78e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—lung cancer	2.51e-06	2.73e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.45e-06	2.67e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—lung cancer	2.33e-06	2.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CREBBP—lung cancer	2.27e-06	2.47e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—lung cancer	2.14e-06	2.33e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—lung cancer	2.12e-06	2.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.87e-06	2.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—lung cancer	1.86e-06	2.02e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—lung cancer	1.85e-06	2.02e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—lung cancer	1.62e-06	1.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—lung cancer	1.54e-06	1.68e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—lung cancer	1.52e-06	1.65e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—lung cancer	9.34e-07	1.02e-05	CbGpPWpGaD
